Clinical Study
Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Table 3
Severity of diabetic retinopathy. Number of eyes per severity level before and after treatment in the three groups. Inactive PDR refers to eyes with complete regression of the new vessels after treatment.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IVB: intravitreal bevacizumab; IVT: intravitreal triamcinolone; PDR: proliferative diabetic retinopathy; PRP: panretinal photocoagulation. |